Skip to content
Governance Register

← US public companies

Avenue Therapeutics, INC.

SEC CIK 1644963 · ATXI · last insider filing 2026-01-06

Directors (from insider filings)

NameCapacity as filedFilings
Herskowitz Neil Director filed 2017 - 2024
Kranzler JAY D Director filed 2017 - 2024
Oltmans Curtis Gale Director filed 2021 - 2024
Charles Faith L. Director filed 2022 - 2024
Maclean Alexandra Director · Chief Executive Officer filed 2022 - 2024
Rosenwald Lindsay A MD Director filed 2017 - 2024
Lu Lucy Director · President, CEO filed 2017 - 2021
Ingram Elizabeth Garrett Director filed 2019 - 2019
Moore Thomas Gregory Director filed 2019 - 2019
Saxena Nishant Director filed 2019 - 2019
Gogtay Jaideep Ashok Director filed 2019 - 2019
Paley Jeffrey Director filed 2017 - 2018
Weiss Michael S Director filed 2017 - 2018
Samad Akhtar Director filed 2017 - 2018

Officers (from insider filings)

NameTitle as filedFilings
Jin David Interim PFO and COO filed 2022 - 2024
Vazzano Joseph Walter VP Finance & Corp. Controller filed 2017 - 2021
Reines Scott Interim Chief Medical Officer filed 2017 - 2018

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.